TiMiSNAR Morgagni Pierantoni

TIMING TO MINIMALLY INVASIVE SURGERY AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR RECTAL CANCER: A MULTICENTER RANDOMIZED CONTROLLED TRIAL

TiMiSNAR Morgagni Pierantoni

   Non categorizzato    21/05/2021  |  0

Riportiamo i link al comunicato stampa della AUSL Romagna sullo studio TiMiSNAR da parte cel centro partecipante di Forlì.

AUSL Romagna

TiMiSNAR

TIMING TO MINIMALLY INVASIVE SURGERY AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR RECTAL CANCER: A MULTICENTER RANDOMIZED CONTROLLED TRIAL

© 2018 TiMiSNAR